NCT05965661

Brief Summary

We investigate the impact of a 4-week virtual reality-based upper limb training in Parkinson's disease. The benefits on dexterity of this training program will be evaluated. For these purposes, a randomised, two arm, single assessor blind, parallel design with a monocentric, study setup will be performed.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
20

participants targeted

Target at P25-P50 for not_applicable parkinson-disease

Timeline
Completed

Started Jul 2023

Typical duration for not_applicable parkinson-disease

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 13, 2023

Completed
6 days until next milestone

Study Start

First participant enrolled

July 19, 2023

Completed
9 days until next milestone

First Posted

Study publicly available on registry

July 28, 2023

Completed
2.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2025

Completed
Last Updated

July 28, 2023

Status Verified

July 1, 2023

Enrollment Period

2.5 years

First QC Date

July 13, 2023

Last Update Submit

July 20, 2023

Conditions

Keywords

Parkinson Diseasevirtual reality trainingdexterityParkinsonian DisordersBasal Ganglia DiseasesBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesMovement DisordersNeurodegenerative Diseases

Outcome Measures

Primary Outcomes (1)

  • fine finger movements

    Coin rotation task (CRT): The CRT measures fine coordinated finger movements and is a suitable and valid dexterity test in patients with PD. The seconds for 20 halfturns will be measured.

    4 weeks

Secondary Outcomes (5)

  • hand dexterity

    4 weeks

  • grip strenght

    4 weeks

  • motor function

    4 weeks

  • self-reported dexterity related problems in daily living

    4 weeks

  • self-reported problems in quality of life

    4 weeks

Study Arms (2)

Virtual reality upper limb hand training

OTHER

The PD patients randomized in the experimental group will receive virtual reality upper limb hand training.

Other: virtual reality upper limb hand training

Virtual reality control training

OTHER

The PD patients randomized in the control group will receive virtual reality control training.

Other: virtual reality control training

Interventions

The PD patients randomized in the experimental group will receive virtual reality upper limb hand training.

Virtual reality upper limb hand training

The PD patients randomized in the control group will receive virtual reality control training.

Virtual reality control training

Eligibility Criteria

Age40 Years - 99 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients with confirmed PD, according to UK Brain bank Criteria
  • Hoehn \& Yahr Stadium I to IV
  • Age 40 to 99 years
  • written and signed informed consent
  • self-reported dexterous difficulties

You may not qualify if:

  • MoCA \<21/30
  • psychiatric disease
  • participation on other interventional trials
  • Inability to follow the procedures of the study, e.g. due to language problems, psychological disorders, dementia, etc.
  • severe visual impairment

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Luzerner Kantonsspital

Lucerne, 6000, Switzerland

RECRUITING

MeSH Terms

Conditions

Parkinson DiseaseParkinsonian DisordersBasal Ganglia DiseasesBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesMovement DisordersNeurodegenerative Diseases

Condition Hierarchy (Ancestors)

Synucleinopathies

Study Officials

  • Tim Vanbellingen, Prof

    Luzerner Kantonsspital

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Cornelia Cox, MSc

CONTACT

Manuela Pastore, PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Masking Details
VR upper limb hand training or VR control training
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Randomized pilot study
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 13, 2023

First Posted

July 28, 2023

Study Start

July 19, 2023

Primary Completion

December 31, 2025

Study Completion

December 31, 2025

Last Updated

July 28, 2023

Record last verified: 2023-07

Data Sharing

IPD Sharing
Will not share

Locations